These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31057543)

  • 1. Immune-Modulation by the Human Respiratory Syncytial Virus: Focus on Dendritic Cells.
    Tognarelli EI; Bueno SM; González PA
    Front Immunol; 2019; 10():810. PubMed ID: 31057543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.
    Gómez RS; Ramirez BA; Céspedes PF; Cautivo KM; Riquelme SA; Prado CE; González PA; Kalergis AM
    Immunology; 2016 Jan; 147(1):55-72. PubMed ID: 26451966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
    González AE; Lay MK; Jara EL; Espinoza JA; Gómez RS; Soto J; Rivera CA; Abarca K; Bueno SM; Riedel CA; Kalergis AM
    Virulence; 2017 Aug; 8(6):685-704. PubMed ID: 27911218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Activation Marker Induction and Chemokine Receptor Switch in Human Neonatal Myeloid Dendritic Cells in Response to Human Respiratory Syncytial Virus.
    Le Nouën C; Hillyer P; Levenson E; Martens C; Rabin RL; Collins PL; Buchholz UJ
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31484754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of host adaptive immunity by hRSV proteins.
    Espinoza JA; Bohmwald K; Céspedes PF; Riedel CA; Bueno SM; Kalergis AM
    Virulence; 2014; 5(7):740-51. PubMed ID: 25513775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection.
    Jung HE; Kim TH; Lee HK
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31952261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CCR7-mediated migration of human monocyte derived dendritic cells in response to human respiratory syncytial virus and human metapneumovirus.
    Le Nouën C; Hillyer P; Winter CC; McCarty T; Rabin RL; Collins PL; Buchholz UJ
    PLoS Pathog; 2011 Jun; 7(6):e1002105. PubMed ID: 21731495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.
    Le Nouën C; Hillyer P; Munir S; Winter CC; McCarty T; Bukreyev A; Collins PL; Rabin RL; Buchholz UJ
    PLoS One; 2010 Nov; 5(11):e15017. PubMed ID: 21124776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD8+ T cell immunity against human respiratory syncytial virus.
    Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
    Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells in human Pneumovirus and Metapneumovirus infections.
    Guerrero-Plata A
    Viruses; 2013 Jun; 5(6):1553-70. PubMed ID: 23787776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.
    Gálvez NMS; Soto JA; Kalergis AM
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis, Humoral Immune Responses, and Transmission between Cohoused Animals in a Ferret Model of Human Respiratory Syncytial Virus Infection.
    Chan KF; Carolan LA; Druce J; Chappell K; Watterson D; Young P; Korenkov D; Subbarao K; Barr IG; Laurie KL; Reading PC
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29187546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development.
    Garg R; Shrivastava P; van Drunen Littel-van den Hurk S
    Expert Rev Vaccines; 2012 Dec; 11(12):1441-57. PubMed ID: 23252388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
    Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
    Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of Fcγ Receptor-Mediated Immunity to the Pathogenesis Caused by the Human Respiratory Syncytial Virus.
    Acevedo OA; Díaz FE; Beals TE; Benavente FM; Soto JA; Escobar-Vera J; González PA; Kalergis AM
    Front Cell Infect Microbiol; 2019; 9():75. PubMed ID: 30984626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.
    Le Nouën C; Munir S; Losq S; Winter CC; McCarty T; Stephany DA; Holmes KL; Bukreyev A; Rabin RL; Collins PL; Buchholz UJ
    Virology; 2009 Mar; 385(1):169-82. PubMed ID: 19128816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody development for preventing the human respiratory syncytial virus pathology.
    Soto JA; Gálvez NMS; Pacheco GA; Bueno SM; Kalergis AM
    Mol Med; 2020 Apr; 26(1):35. PubMed ID: 32303184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.